Search research articles
Contact Us
Filters
Showing results (81-90 of 188) with videos related to
Page
of 19
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 17, 2008
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs
Zaorui Zhao, Han-Ting Zhang, Elianna Bootzin, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 28, 2009
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptors
Jean-Louis Peglion, Christophe Poitevin, Clotilde Mannoury La Cour, et al.
Journal of Neurochemistry
|
November 21, 2007
Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes
Clotilde Mannoury la Cour, Chloé Herbelles, Valérie Pasteau, et al.
The Journal of Biological Chemistry
|
February 1, 2012
Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface
Chantevy Pou, Clotilde Mannoury la Cour, Leigh A Stoddart, et al.
Brain Research
|
April 3, 2012
Quantification of extracellular levels of corticosterone in the basolateral amygdaloid complex of freely-moving rats: a dialysis study of circadian variation and stress-induced modulation
Gaëlle Bouchez, Mark J Millan, Jean-Michel Rivet, et al.
The International Journal of Neuropsychopharmacology
|
March 19, 2011
Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment
David J G Watson, Charles A Marsden, Mark J Millan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 26, 2015
Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: Reversal by blockade of CRF1 receptors
Elisabeth Y Bijlsma, Hendrikus Hendriksen, Johanna M P Baas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
Mark J Millan, Lisa Maiofiss, Didier Cussac, et al.
Journal of Neurochemistry
|
December 20, 2015
Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors
Nathalie Schmieg, Cristina Rocchi, Stefania Romeo, et al.
Nature Reviews. Drug Discovery
|
June 26, 2010
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
Christian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 188) with videos related to
Sort By:
Page
of 19
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 17, 2008
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs
Zaorui Zhao, Han-Ting Zhang, Elianna Bootzin, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 28, 2009
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptors
Jean-Louis Peglion, Christophe Poitevin, Clotilde Mannoury La Cour, et al.
Journal of Neurochemistry
|
November 21, 2007
Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes
Clotilde Mannoury la Cour, Chloé Herbelles, Valérie Pasteau, et al.
The Journal of Biological Chemistry
|
February 1, 2012
Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface
Chantevy Pou, Clotilde Mannoury la Cour, Leigh A Stoddart, et al.
Brain Research
|
April 3, 2012
Quantification of extracellular levels of corticosterone in the basolateral amygdaloid complex of freely-moving rats: a dialysis study of circadian variation and stress-induced modulation
Gaëlle Bouchez, Mark J Millan, Jean-Michel Rivet, et al.
The International Journal of Neuropsychopharmacology
|
March 19, 2011
Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment
David J G Watson, Charles A Marsden, Mark J Millan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 26, 2015
Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: Reversal by blockade of CRF1 receptors
Elisabeth Y Bijlsma, Hendrikus Hendriksen, Johanna M P Baas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
Mark J Millan, Lisa Maiofiss, Didier Cussac, et al.
Journal of Neurochemistry
|
December 20, 2015
Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors
Nathalie Schmieg, Cristina Rocchi, Stefania Romeo, et al.
Nature Reviews. Drug Discovery
|
June 26, 2010
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
Christian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, et al.
Page
of 19